Workflow
Q1 2025 financial results
icon
Search documents
PyroGenesis Schedules First Quarter 2025 Financial Results and Business Update Conference Call
Globenewswire· 2025-05-09 11:30
Core Viewpoint - PyroGenesis Inc. is set to host a conference call on May 14, 2025, to discuss its financial results for Q1 2025 and provide updates on company progress and developments [1]. Company Overview - PyroGenesis is a high-tech company specializing in advanced all-electric plasma processes and sustainable solutions aimed at supporting heavy industries in energy transition, emission reduction, commodity security, and waste remediation [1][3]. - The company has developed proprietary and patented plasma technologies that are being adopted by major industry players in four key markets: iron ore pelletization, aluminum, waste management, and additive manufacturing [3]. - PyroGenesis operates from its Montreal office and has manufacturing facilities of 3,800 m² and 2,940 m², maintaining a competitive edge through continuous technology development and commercialization [3]. - The company is ISO 9001:2015 and AS9100D certified, having been ISO certified since 1997 [3]. - PyroGenesis' shares are publicly traded on the TSX (TSX: PYR), OTCQX (OTCQX: PYRGF), and Frankfurt Stock Exchange (FRA: 8PY1) [3].
Gogo Announces First Quarter 2025 Results
Globenewswire· 2025-05-09 11:00
Core Insights - Gogo Inc. reported total revenue of $230.3 million for Q1 2025, representing a 121% increase year-over-year and a 67% increase compared to Q4 2024 [3][34] - Service revenue reached $198.6 million, up 143% year-over-year, while equipment revenue was $31.7 million, a 40% increase year-over-year [3][34] - The company achieved PMA approval for its larger LEO antenna, FDX, ahead of schedule, which is expected to enhance service revenue starting in Q1 2026 [5] Financial Performance - Net income for Q1 2025 was $12.0 million, compared to $30.5 million in Q1 2024 and a net loss of $28.2 million in Q4 2024 [3][22] - Adjusted EBITDA for Q1 2025 was $62.1 million, reflecting a 43% increase year-over-year and an 83% increase compared to Q4 2024 [3][37] - Free Cash Flow for Q1 2025 was $30.0 million, down from $32.1 million in the prior-year period but up from a negative $39.6 million in Q4 2024 [9][37] Operational Metrics - Total ATG AVANCE aircraft online grew to 4,716, a 15% increase year-over-year [3][31] - Average Monthly Connectivity Service Revenue per ATG aircraft online was $3,451, remaining flat compared to Q1 2024 [3][31] - The company shipped 59 HDX antennas year-to-date, with 38 HDX Supplemental Type Certificates under contract, targeting a total addressable market of nearly 32,000 aircraft [9][9] Strategic Outlook - Gogo reiterated its 2025 financial guidance, projecting total revenue between $870 million and $910 million and adjusted EBITDA between $200 million and $220 million [6][7] - The company anticipates Free Cash Flow in the range of $60 million to $90 million for 2025, with capital expenditures of approximately $60 million [7][39] - Gogo plans to provide longer-term financial targets later in 2025, with preliminary targets indicating 10% revenue growth and adjusted EBITDA margins in the mid-20s [8]
InspireMD Reports First Quarter 2025 Financial Results
Globenewswire· 2025-05-09 11:00
Management to host investor conference call today, May 9th, at 8:30am ETMIAMI, May 09, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Prime carotid stent system for the treatment of carotid artery disease and prevention of stroke, today announced financial and operating results for the first quarter ended March 31, 2025. Business Highlights: Continued engagement with the U.S. Food and Drug Administration (FDA) on the Premarket Approval (PMA) application for the CGuard Prim ...
Rapid Micro Biosystems Reports First Quarter 2025 Financial Results
Globenewswire· 2025-05-09 11:00
Reports first quarter 2025 total revenue of $7.2 million, representing 28% growth compared to the first quarter of 2024. Reports record quarterly service revenue led by strong validation activity. Reports first quarter gross margin of 6%, representing a 33-percentage point improvement compared to the first quarter of 2024.Announced a global Distribution and Collaboration Agreement with the Life Science business of Merck KGaA, Darmstadt, Germany, which operates in the U.S. as MilliporeSigma (“MilliporeSigma ...
Protalix BioTherapeutics Reports First Quarter 2025 Financial and Business Results
Prnewswire· 2025-05-09 10:50
Core Viewpoint - Protalix BioTherapeutics reported strong financial results for Q1 2025, with significant revenue growth driven by increased sales, and is advancing its clinical pipeline, particularly focusing on the gout treatment candidate PRX-115 [2][7][14]. Financial Highlights - Revenues from selling goods reached $10.0 million for the three months ended March 31, 2025, an increase of $6.3 million, or 170%, compared to $3.7 million for the same period in 2024 [7]. - Revenues from license and R&D services were $0.1 million for both Q1 2025 and Q1 2024, primarily from agreements with Chiesi [7]. - Cost of goods sold was $8.2 million for Q1 2025, up $5.6 million, or 215%, from $2.6 million in Q1 2024 [7]. - Total research and development expenses were approximately $3.5 million for Q1 2025, a 21% increase from $2.9 million in Q1 2024 [8][13]. - The net loss for Q1 2025 was approximately $3.6 million, or $0.05 per share, compared to a net loss of $4.6 million, or $0.06 per share, for the same period in 2024 [13][20]. Clinical and Pipeline Developments - Protalix is preparing to initiate a phase II clinical trial for PRX-115, a treatment for uncontrolled gout, later in 2025, following promising results from a phase I trial completed in 2024 [2][6]. - The preliminary results of the phase I trial indicated that PRX-115 has the potential for effective uric acid-lowering treatment with a wide dosing interval [6]. - The company is also evaluating additional pipeline candidates, including PRX-119 and various early-stage clinical assets [2]. Partnerships and Collaborations - Protalix has partnered with Chiesi Global Rare Diseases for the global development and commercialization of its products, including Elfabrio® [4][15]. - The company has licensed worldwide development and commercialization rights for taliglucerase alfa to Pfizer Inc. for the treatment of Gaucher disease [14]. Market Presence - Protalix is recognized for its proprietary ProCellEx® plant cell-based protein expression system, which is a novel method for developing recombinant proteins at an industrial scale [14]. - The company has achieved FDA approval for its products, marking significant milestones in its commercialization efforts [14].
Target Hospitality Announces First Quarter 2025 Earnings Release and Conference Call Schedule
Prnewswire· 2025-05-09 10:45
Core Points - Target Hospitality Corp. will release its first quarter 2025 financial results on May 19, 2025, before the market opens [1] - A conference call to discuss the results is scheduled for the same day at 9:00 AM Eastern Time [1][3] - The conference call will be accessible via live webcast on the company's website [2] Company Overview - Target Hospitality is one of North America's largest providers of vertically integrated modular accommodations and value-added hospitality services [5] - The company builds, owns, and operates a customized network of communities, offering a full suite of services including food service management, concierge, laundry, logistics, security, and recreational facilities [5]
Gravity Reports First Quarter of 2025 Results and Business Update
Globenewswire· 2025-05-09 10:15
Core Viewpoint - Gravity Co., Ltd. reported its unaudited financial results for Q1 2025, showing mixed performance across its online and mobile game segments, with overall revenue growth year-over-year but some declines quarter-over-quarter in specific areas [1][3][9]. Financial Results Summary Revenues - Online game revenues for Q1 2025 were KRW 18,806 million (US$ 12,755 thousand), a 5.1% decrease QoQ and a 4.1% increase YoY [3]. - Mobile game revenues reached KRW 115,486 million (US$ 78,325 thousand), reflecting a 9.4% increase QoQ and a 17.2% increase YoY [4]. - Other revenues totaled KRW 3,172 million (US$ 2,151 thousand), showing a 26.5% decrease QoQ but a slight 0.2% increase YoY [5]. Cost of Revenue - Cost of revenue was KRW 87,458 million (US$ 59,316 thousand), representing an 8% increase QoQ and an 18.8% increase YoY [6]. Operating Expenses - Operating expenses were KRW 25,276 million (US$ 17,143 thousand), a 22.9% decrease QoQ and a 31.1% increase YoY [7]. Profitability - Profit before income tax expenses was KRW 28,450 million (US$ 19,295 thousand), a 12.1% increase QoQ but a 12.5% decrease YoY [8]. - Net profit attributable to the parent company was KRW 22,038 million (US$ 14,947 thousand), a 4.6% decrease QoQ and an 18% decrease YoY [9]. Liquidity - As of March 31, 2025, the balance of cash and cash equivalents and short-term financial instruments was KRW 577,163 million (US$ 391,446 thousand) [10]. Business Updates Summary Game Launches - Ragnarok M: Classic launched in Southeast Asia on February 14, 2025, and in Taiwan, Hong Kong, and Macau on April 16, 2025 [12]. - Ragnarok Idle Adventure Plus launched globally on February 20, 2025, with further launches planned for Taiwan, Hong Kong, and Macau in Q2 2025 [12]. - Ragnarok X: Next Generation launched in various regions on May 8, 2025, with a European launch planned for Q2 2025 [12]. - Other games such as Ragnarok V: Returns and Ragnarok: Back to Glory were launched in Southeast Asia and Korea in March and April 2025, respectively [12]. Expansion Initiatives - Gravity established a new subsidiary, Gravity Game Unite, in Malaysia on March 12, 2025, to expand game services in the region [17]. - The company opened its first indoor-screen golf facility based on Ragnarok characters in Taipei, Taiwan, on February 27, 2025 [16].
Super Hi to Report First Quarter 2025 Financial Results on Wednesday, May 21, 2025
Globenewswire· 2025-05-09 10:00
Earnings Call Scheduled for 8:00 a.m. ET on May 21, 2025SINGAPORE, May 09, 2025 (GLOBE NEWSWIRE) -- Super Hi International Holding Ltd. ("Super Hi" or the "Company") (NASDAQ: HDL and HKEX: 9658), a leading Chinese cuisine restaurant brand operating Haidilao hot pot restaurants in the international market, today announced that it will report its unaudited financial results for the first quarter of FY2025 on Wednesday, May 21, 2025, before the open of U.S. markets. The Company's management will host an earnin ...
Yalla Group Limited to Report First Quarter 2025 Financial Results on May 19, 2025 Eastern Time
Prnewswire· 2025-05-09 10:00
Core Viewpoint - Yalla Group Limited, the largest online social networking and gaming company in the MENA region, is set to announce its unaudited financial results for Q1 2025 on May 19, 2025, after U.S. market close [1] Company Overview - Yalla Group Limited operates two main mobile applications: Yalla, a voice-centric group chat platform, and Yalla Ludo, a casual gaming app featuring online board games popular in MENA [3] - The company has expanded its offerings through Yalla Game Limited, focusing on mid-core and hard-core games, and has developed additional products like YallaChat and WeMuslim to cater to Arabic users [3] - Yalla is also exploring opportunities outside MENA with Yalla Parchis, a Ludo game aimed at South American markets [3] Financial Communication - A conference call to discuss the financial results will be held on May 19, 2025, at 8:00 PM Eastern Time, with access numbers provided for various regions [2] - The replay of the conference call will be available until May 26, 2025, along with a live and archived webcast on the company's investor relations website [2]
Yatsen to Announce First Quarter 2025 Financial Results on May 16, 2025
Prnewswire· 2025-05-09 09:00
Core Viewpoint - Yatsen Holding Limited, a leading beauty group based in China, is set to release its unaudited financial results for Q1 2025 on May 16, 2025, before U.S. market opening [1]. Financial Results Announcement - The financial results will be discussed in a conference call scheduled for May 16, 2025, at 7:30 A.M. U.S. Eastern Time [2]. - The call can be accessed via multiple toll-free numbers for the U.S., international, and Mainland China listeners [2]. Company Overview - Yatsen Holding Limited was founded in 2016 and has launched and acquired several beauty brands, including Perfect Diary, Little Ondine, and DR.WU [3]. - Perfect Diary is recognized as one of the leading color cosmetics brands in China based on retail sales value [3]. - The company engages with customers through both online and offline channels, maintaining a strong presence across major e-commerce and social platforms in China [3].